Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept plus methotrexate versus methotrexate alone in early ACPA-positive rheumatoid arthritis
NL-OMON50283Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in rheumatoid arthritis (RA) comparing Methotrexate monotherapy with Abatacept plus methotrexate (2 arms). Started May 2018; status: active, not recruiting.
02
Drugs
abataceptmethotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON50283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50283.